Lew, Daniel
Afghani, Elham
Pandol, Stephen
Funding for this research was provided by:
National Institutes of Health (NIH P01 CA163200, P50 AA11999, P01 DK098108, U01 DK108314, DCP NWU2014-04-01)
U.S. Department of Defense (PR140717P2)
Article History
Received: 16 December 2016
Accepted: 2 May 2017
First Online: 13 May 2017
Compliance with ethical standards
:
: This work was supported by the following US federal grants: CA163200, AA11999, DK098108, DoD PR140717P2, DK108314, DCP NWU2014-04-01, W81XWH-16-PRMRP-DA. Dr. Pandol is a founder of Avenzoar Pharmaceuticals and a consultant for Allergan and SunBiopharma. There is no information in this work representing a commercial conflict of interest. Dr. Lew and Dr. Afghani do not have any conflict of interests.